Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis.

Wolf T, Fuß B, Khaykin P, Berger A, Knecht G, Gute P, Brodt HR, Goepel S, Bickel M, Stuermer M, Stephan C.

Med Microbiol Immunol. 2014 Aug 23. [Epub ahead of print]

PMID:
25148909
[PubMed - as supplied by publisher]
2.

Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment.

Khaykin P, Kotzerke P, Stephan C, Nisius G, Bickel M, Haberl A, Stürmer M, Kurowski M, Brodt R, von Hentig N.

Ther Drug Monit. 2014 Apr;36(2):192-201. doi: 10.1097/FTD.0b013e3182a28c6a.

PMID:
24632753
[PubMed - in process]
3.

Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.

Bickel M, Khaykin P, Stephan C, Schmidt K, Buettner M, Amann K, Lutz T, Gute P, Haberl A, Geiger H, Brodt HR, Jung O.

HIV Med. 2013 Nov;14(10):633-8. doi: 10.1111/hiv.12072. Epub 2013 Aug 28.

PMID:
23980564
[PubMed - indexed for MEDLINE]
4.

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BS, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR.

AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95.

PMID:
23925379
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States.

Antiretroviral Therapy Cohort Collaboration (ART-CC).

Clin Infect Dis. 2013 Jun;56(12):1800-9. doi: 10.1093/cid/cit111. Epub 2013 Mar 1.

PMID:
23457077
[PubMed - indexed for MEDLINE]
Free Article
6.

Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.

Wolf T, Goetsch U, Oremek G, Bickel M, Khaykin P, Haberl A, Bellinger O, Gottschalk R, Brodt HR, Stephan C.

J Infect. 2013 Apr;66(4):376-80. doi: 10.1016/j.jinf.2012.11.004. Epub 2012 Nov 15.

PMID:
23159357
[PubMed - indexed for MEDLINE]
7.

End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years.

Bickel M, Marben W, Betz C, Khaykin P, Stephan C, Gute P, Haberl A, Knecht G, Wolf T, Brodt HR, Geiger H, Herrmann E, Jung O.

HIV Med. 2013 Mar;14(3):127-35. doi: 10.1111/j.1468-1293.2012.01045.x. Epub 2012 Sep 20.

PMID:
22994610
[PubMed - indexed for MEDLINE]
8.

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy.

Stephan C, Bartha V, Herrmann E, von Hentig N, Khaykin P, Knecht G, Gute P, Brodt HR, Stürmer M, Berger A, Bickel M.

Med Microbiol Immunol. 2013 Apr;202(2):117-24. doi: 10.1007/s00430-012-0276-8. Epub 2012 Sep 15.

PMID:
22983722
[PubMed - indexed for MEDLINE]
9.

The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.

Murray M, Hogg RS, Lima VD, May MT, Moore DM, Abgrall S, Bruyand M, D'Arminio Monforte A, Tural C, Gill MJ, Harris RJ, Reiss P, Justice A, Kirk O, Saag M, Smith CJ, Weber R, Rockstroh J, Khaykin P, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

HIV Med. 2012 Feb;13(2):89-97. doi: 10.1111/j.1468-1293.2011.00940.x. Epub 2011 Aug 7.

PMID:
21819529
[PubMed - indexed for MEDLINE]
10.

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Herrmann E, Doerr HW, Brodt HR, Allwinn R.

Clin Infect Dis. 2011 Jan 1;52(1):122-7. doi: 10.1093/cid/ciq003.

PMID:
21148530
[PubMed - indexed for MEDLINE]
Free Article
11.

Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Schulze Zur Wiesch J, Thomssen A, Hartjen P, Tóth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, Degen O, Mauss S, Rockstroh J, Staszewski S, Khaykin P, Strasak A, Lohse AW, Fätkenheuer G, Hauber J, van Lunzen J.

J Virol. 2011 Feb;85(3):1287-97. doi: 10.1128/JVI.01758-10. Epub 2010 Nov 3.

PMID:
21047964
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study.

Puls RL, Srasuebkul P, Petoumenos K, Boesecke C, Duncombe C, Belloso WH, Molina JM, Li L, Avihingsanon A, Gazzard B, Cooper DA, Emery S; Altair Study Group.

Clin Infect Dis. 2010 Oct 1;51(7):855-64. doi: 10.1086/656363.

PMID:
20735258
[PubMed - indexed for MEDLINE]
Free Article
13.

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN.

Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15.

PMID:
20638118
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.

Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von Hentig N, Herrmann E, Doerr HW, Brodt HR, Allwinn R.

AIDS. 2010 Jun 1;24(9):F31-5. doi: 10.1097/QAD.0b013e3283398da1.

PMID:
20559034
[PubMed - indexed for MEDLINE]
15.

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.

Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK.

Eur J Med Res. 2010 Mar 30;15(3):102-11.

PMID:
20452894
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.

Antiretroviral Therapy Cohort Collaboration.

Clin Infect Dis. 2010 May 15;50(10):1387-96. doi: 10.1086/652283.

PMID:
20380565
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.

Haberl A, Moesch M, Nisius G, Stephan C, Bickel M, Khaykin P, Kurowski M, Brodt R, von Hentig N.

Eur J Clin Pharmacol. 2010 Apr;66(4):375-81. doi: 10.1007/s00228-009-0767-8. Epub 2009 Dec 24.

PMID:
20033681
[PubMed - indexed for MEDLINE]
18.

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M, Khaykin P, de Wolf F, Sterne JA, Costagliola D.

AIDS. 2009 Oct 23;23(16):2199-208. doi: 10.1097/QAD.0b013e3283305a00.

PMID:
19779320
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?

Stephan C, Dauer B, Khaykin P, Stuermer M, Gute P, Klauke S, Staszewski S.

Curr HIV Res. 2009 May;7(3):320-6.

PMID:
19442129
[PubMed - indexed for MEDLINE]
20.

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M.

Clin Infect Dis. 2009 Apr 15;48(8):1138-51. doi: 10.1086/597468.

PMID:
19275498
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk